Could a Parkinson's pill also fight gum disease?
NCT ID NCT07405268
Summary
This study aims to understand if a standard Parkinson's disease medication (Levodopa-Benserazide) has any effect on gum health and inflammation. Researchers will compare gum health and saliva samples from 136 people across four groups: those with Parkinson's and gum disease, those with Parkinson's and healthy gums, and two groups without Parkinson's. The goal is to see if the medication is linked to better or worse gum health and different levels of inflammation markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIODONTAL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.